Contribution of Influenza Viruses, Other Respiratory Viruses and Viral Co-Infections to Influenza-like Illness in Older Adults
Overview
Authors
Affiliations
Influenza-like illness (ILI) can be caused by a range of respiratory viruses. The present study investigates the contribution of influenza and other respiratory viruses, the occurrence of viral co-infections, and the persistence of the viruses after ILI onset in older adults. During the influenza season 2014-2015, 2366 generally healthy community-dwelling older adults (≥60 years) were enrolled in the study. Viruses were identified by multiplex ligation-dependent probe-amplification assay in naso- and oropharyngeal swabs taken during acute ILI phase, and 2 and 8 weeks later. The ILI incidence was 10.7%, which did not differ between vaccinated and unvaccinated older adults; influenza virus was the most frequently detected virus (39.4%). Other viruses with significant contribution were: rhinovirus (17.3%), seasonal coronavirus (9.8%), respiratory syncytial virus (6.7%), and human metapneumovirus (6.3%). Co-infections of influenza virus with other viruses were rare. The frequency of ILI cases in older adults in this 2014-2015 season with low vaccine effectiveness was comparable to that of the 2012-2013 season with moderate vaccine efficacy. The low rate of viral co-infections observed, especially for influenza virus, suggests that influenza virus infection reduces the risk of simultaneous infection with other viruses. Viral persistence or viral co-infections did not affect the clinical outcome of ILI.
Amour S, Rubio A, Orsi A, Oppert M, Loebermann M, Del Pozo Vegas C Influenza Other Respir Viruses. 2024; 18(11):e70040.
PMID: 39568106 PMC: 11578834. DOI: 10.1111/irv.70040.
van der Heiden M, Shetty S, Bijvank E, Beckers L, Cevirgel A, van Sleen Y Nat Commun. 2024; 15(1):6603.
PMID: 39097574 PMC: 11297912. DOI: 10.1038/s41467-024-50760-9.
Epidemiologic and clinical updates on viral infections in Saudi Arabia.
Alshiban N, Aleyiydi M, Nassar M, Alhumaid N, Almangour T, Tawfik Y Saudi Pharm J. 2024; 32(7):102126.
PMID: 38966679 PMC: 11223122. DOI: 10.1016/j.jsps.2024.102126.
Badruzzaman A, Cheng Y, Sung W, Lee M Vaccines (Basel). 2024; 12(6).
PMID: 38932396 PMC: 11209530. DOI: 10.3390/vaccines12060667.
Ozgen-Top O, Aysert-Yildiz P, Ozger H, Guzel-Tunccan O Infect Dis Clin Microbiol. 2024; 5(4):323-331.
PMID: 38633854 PMC: 10986686. DOI: 10.36519/idcm.2023.285.